Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis - Möhle, Robert; Pförsich, Margit; Frühauf, Stefan; Witt, Barbara; Krämer, Alwin; Haas, Rainer (Bone marrow transplantation, 1994)